Sponsor or institution
Clinical trials and research at Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
As of November 12, 2026, Find a Trial lists 7 clinical trials run by Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany that are recruiting, at sites in 26 countries (most in United States (3), Japan (3), Germany (3)). By phase: Phase 1 (3), Phase 3 (2), Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 26Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How probenecid affects mirdametnib in healthy adults | Phase 1 | Neu-Ulm | Recruiting | Sep 25, 2026 |
| Pimicotinib for Japanese people with tenosynovial giant cell tumor (J-MANEUVER) | Phase 2 | Chūōku and 3 other locations | Recruiting | Mar 30, 2026 |
| Comparing follitropin alfa/lutropin alfa versus hMG for Japanese women with LH and FSH deficiency undergoing assisted reproductive treatment. | Phase 3 | Akita, Akita and 20 other locations | Recruiting | Jan 14, 2026 |
| Nirogacestat for premenopausal women with desmoid tumors | Phase 4 | Brussels and 22 other locations | Recruiting | Sep 16, 2025 |
| Impact of liver function on how the body processes Mirdametinib | Phase 1 | Miami, Florida and 2 other locations | Recruiting | May 30, 2025 |
| New oral cladribine formulation for treating generalized myasthenia gravis | Phase 3 | Phoenix, Arizona and 153 other locations | Recruiting | Jun 18, 2024 |
| SW-682 for advanced solid tumors | Phase 1 | Scottsdale, Arizona and 7 other locations | Recruiting | Feb 9, 2024 |
All recruiting trials (7)
-
How probenecid affects mirdametnib in healthy adults
This study tests how taking probenecid changes the way mirdametnib and its metabolites behave in the body of healthy adults.
-
Pimicotinib for Japanese people with tenosynovial giant cell tumor (J-MANEUVER)
This trial will test whether pimicotinib is safe, reaches effective blood levels, and improves symptoms in Japanese participants with unresectable tenosynovial giant cell tumor.
-
Comparing follitropin alfa/lutropin alfa versus hMG for Japanese women with LH and FSH deficiency undergoing assisted reproductive treatment.
This will test whether a combined follitropin alfa/lutropin alfa injection works as well as hMG for Japanese premenopausal women with LH and FSH deficiency who are undergoing assisted reproductive technology.
-
Nirogacestat for premenopausal women with desmoid tumors
This trial tests whether nirogacestat affects ovarian function in premenopausal women (ages 18–40) with progressing desmoid tumors.
-
Impact of liver function on how the body processes Mirdametinib
This study is testing how well the body processes a drug called Mirdametinib in people with liver problems compared to healthy volunteers to see if there are any differences in how the drug works.
-
New oral cladribine formulation for treating generalized myasthenia gravis
This study is testing a new pill for people with generalized myasthenia gravis to see if it helps them feel better compared to a sugar pill.
-
SW-682 for advanced solid tumors
This study is testing a new oral treatment called SW-682 to see if it can help adults with advanced solid tumors that haven't improved with other therapies.
Quick answers
How many clinical trials run by Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 26 countries. The most sites are in United States (3 trials), Japan (3 trials), Germany (3 trials), Belgium (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 3: 2, Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.